Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cisplatin-gemcitabine chemotherapy (GFPC 03-01 Study).
Vergnenègre A, Tillon J, Corre R, Barlési F, Berard H, Vernejoux JM, Le Caer H, Fournel P, Marin B, Chouaïd C. Vergnenègre A, et al. Among authors: vernejoux jm. J Thorac Oncol. 2009 Mar;4(3):364-70. doi: 10.1097/JTO.0b013e318197f4ff. J Thorac Oncol. 2009. PMID: 19155999 Free article. Clinical Trial.
Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
Decroisette C, Monnet I, Berard H, Quere G, Le Caer H, Bota S, Audigier-Valette C, Geriniere L, Vernejoux JM, Chouaid C; Groupe Français de Pneumo-Cancérologie 0601 Team. Decroisette C, et al. Among authors: vernejoux jm. J Thorac Oncol. 2011 Mar;6(3):576-82. doi: 10.1097/JTO.0b013e318206a1e3. J Thorac Oncol. 2011. PMID: 21270669 Free article.
Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study.
Pérol M, Léna H, Thomas P, Robinet G, Fournel P, Coste E, Belleguic C, Le Caer H, Blanchon F, Vergnenègre A, Vernejoux JM, Schuller-Lebeau MP, Pham E. Pérol M, et al. Among authors: vernejoux jm. Ann Oncol. 2002 May;13(5):742-7. doi: 10.1093/annonc/mdf128. Ann Oncol. 2002. PMID: 12075743 Free article. Clinical Trial.
40 results